CLINICAL OUTCOMES OF TEGOPRAZAN OR PPI COMBINATION THERAPY IN PATIENTS TAKING ANTIPLATELET AGENTS AFTER PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Lee, Jin
Park, Jongha
Park, Jino
Na, Ji Eun
Park, Yong Eun
Choi, Joon Hyuk
Kim, Tae Oh
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1360
引用
收藏
页码：S1313 / S1314
页数：2
相关论文
共 50 条
  • [11] Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention
    Foo, Fiona
    Oldroyd, Keith G.
    BIOMARKERS IN MEDICINE, 2011, 5 (01) : 9 - 30
  • [12] The impact of PEAR 1 polymorphism on clinical outcomes in Chinese patients receiving dual antiplatelet therapy after percutaneous coronary intervention
    Hu, Xinyuan
    Liu, Chaoxi
    Zhang, Mingyou
    Zhang, Weihua
    PHARMACOGENOMICS, 2022, 23 (11) : 639 - 648
  • [13] Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention
    Braunwald, Eugene
    Angiolillo, Dominick
    Bates, Eric
    Berger, Peter B.
    Bhatt, Deepak
    Cannon, Christopher P.
    Furman, Mark I.
    Gurbel, Paul
    Michelson, Alan D.
    Peterson, Eric
    Wiviott, Stephen
    CLINICAL CARDIOLOGY, 2008, 31 (03) : I28 - I35
  • [14] Efficacy of triple antiplatelet therapy for diabetic patients after percutaneous coronary intervention
    Han, Yaling
    Zang, Hongyun
    Li, Yi
    Wang, Shouli
    Jing, Quanmin
    Ma, Yingyan
    Wang, Dongmei
    Wang, Zulu
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 54L - 54L
  • [15] Duration of dual antiplatelet therapy and outcomes after left main percutaneous coronary intervention
    Hu, Tao
    CARDIOLOGY, 2014, 129 : 74 - 74
  • [16] Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Yeh, Robert W.
    Kereiakes, Dean J.
    Steg, P. Gabriel
    Cutlip, Donald E.
    Croce, Kevin J.
    Massaro, Joseph M.
    Mauri, Laura
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : 2213 - 2223
  • [17] Duration Of Dual Antiplatelet Therapy And Outcomes After Left Main Percutaneous Coronary Intervention
    Hu, Tao
    Wang, Hai Chang
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 85S - 86S
  • [18] Pharmacist-led personalisation of antiplatelet therapy and outcomes after percutaneous coronary intervention
    Formosa, R.
    Wirth, F.
    Xuereb, R. G.
    Azzopardi, L. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 789 - 789
  • [19] Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin
    Agarwal, Sanjeev Kumar
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (05) : 308 - 310
  • [20] DURATION OF DUAL ANTIPLATELET THERAPY AND OUTCOMES AFTER LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION
    Hu, Tao
    Wang, Hai-Chang
    HEART, 2012, 98 : E209 - E209
12345